Jenburkt Pharmaceuticals P/E Ratio
Current P/E Ratio
14.67
Low Valuation
Low - May indicate good value opportunity
Jenburkt Pharmaceuticals (JENBURPH) P/E ratio is 14.67 (Low), EPS (TTM) ₹78.71, current price ₹1157.65 on BSE — Low - May indicate good value opportunity. Browse JENBURPH complete financial statements for revenue, profit, balance sheet and cash flow data.
Current Valuation Metrics
P/E Ratio
14.67
Current Price
₹1157.65
EPS (TTM)
₹78.71
Exchange
BSE
Valuation Signal
Signal
Fairly Valued
Sector Context
Sector Average
49.23
Sector Median
29.34
Sector Rank
#11 of 193
Sector Percentile
5.7%
JENBURPH P/E Ratio — Valuation Signal & Historical Context
Jenburkt Pharmaceuticals P/E 14.67 — signal: Fairly Valued. For live price, revenue and the complete fundamental profile, see Jenburkt Pharmaceuticals share price chart.
- Stock appears undervalued with PE of 14.67, suggesting potential buying opportunity
- Trading at discount to sector average PE of 49.23
JENBURPH vs Healthcare Peers — P/E Ratio Comparison
Jenburkt Pharmaceuticals P/E 14.67 vs Healthcare average 49.23, median 29.34 — range 0.97–869.57.
Sector Average
49.23
Sector Median
29.34
Lowest P/E
0.97
Highest P/E
869.57
Companies
193
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 0.97 | ₹36 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.13 | ₹53 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.39 | ₹7,561 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.61 | ₹1,146 | Low |
| Amwill Health Care | AMWILL | 6.04 | ₹65 | Low |
| Mono Pharmacare | MONOPHARMA | 6.85 | ₹20 | Low |
| Medicamen Organics | MEDIORG | 6.94 | ₹28 | Low |
| Brooks Laboratories | BROOKS | 7.38 | ₹166 | Low |
| Shelter Pharma | SHELTER | 7.4 | ₹54 | Low |